PATENT CLAIM ANALYSIS

Application Number: 15770737
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "356000"]

Abstract:
The present specification provides methods of treating nervous system disorders with a thyroid hormone neutral dose of a RXR agonist to promote remyelination or neuroprotection or both and thereby maintain or regenerate healthy axons and neurons.

Claim (Index 28):
A method of promoting survival or repair of neurons or glial cells comprising administering a combination of a thyroid hormone neutral dose of an RXR agonist in combination with a neurotrophic factor or neurotrophic factor mimetic to a patient with a disease of the nervous system wherein the thyroid hormone neutral dose of RXR agonist results in an improved survival or repair of neurons or glial cells in the patient as compared to a dose of the RXR agonist which causes a substantial decrease in plasma T4 levels.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 91.0
- Lexical Diversity: 1.15625
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15812821', '15339752', '15339762', '14507730', '10477876']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8459982296789175
- 35 USC 102 Novelty (BERT): 0.6180784251104771
- Combined Prediction Score: 0.8232062492220735
- Mean Citation Score: 525.456226
- Max Citation Score: 623.54266
- Similarity Product: 460.0255435989785

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test